Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland.
Department of Nuclear Medicine and Molecular Imaging, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Mol Genet Metab. 2021 Dec;134(4):287-300. doi: 10.1016/j.ymgme.2021.10.003. Epub 2021 Nov 10.
Glutaric aciduria type I (GA-I, OMIM # 231670) is an autosomal recessive inborn error of metabolism caused by deficiency of the mitochondrial enzyme glutaryl-CoA dehydrogenase (GCDH). The principal clinical manifestation in GA-I patients is striatal injury most often triggered by catabolic stress. Early diagnosis by newborn screening programs improved survival and reduced striatal damage in GA-I patients. However, the clinical phenotype is still evolving in the aging patient population. Evaluation of long-term outcome in GA-I patients recently identified glomerular filtration rate (GFR) decline with increasing age. We recently created the first knock-in rat model for GA-I harboring the mutation p.R411W (c.1231 C>T), corresponding to the most frequent GCDH human mutation p.R402W. In this study, we evaluated the effect of an acute metabolic stress in form of high lysine diet (HLD) on young Gcdh rats. We further studied the chronic effect of GCDH deficiency on kidney function in a longitudinal study on a cohort of Gcdh rats by repetitive Ga-EDTA positron emission tomography (PET) renography, biochemical and histological analyses. In young Gcdh rats exposed to HLD, we observed a GFR decline and biochemical signs of a tubulopathy. Histological analyses revealed lipophilic vacuoles, thinning of apical brush border membranes and increased numbers of mitochondria in proximal tubular (PT) cells. HLD also altered OXPHOS activities and proteome in kidneys of Gcdh rats. In the longitudinal cohort, we showed a progressive GFR decline in Gcdh rats starting at young adult age and a decline of renal clearance. Histopathological analyses in aged Gcdh rats revealed tubular dilatation, protein accumulation in PT cells and mononuclear infiltrations. These observations confirm that GA-I leads to acute and chronic renal damage. This raises questions on indication for follow-up on kidney function in GA-I patients and possible therapeutic interventions to avoid renal damage.
I 型戊二酸血症(GA-I,OMIM #231670)是一种常染色体隐性遗传代谢缺陷病,由线粒体酶谷氨酸酰辅酶 A 脱氢酶(GCDH)缺乏引起。GA-I 患者的主要临床表现是纹状体损伤,通常由分解代谢应激引起。通过新生儿筛查计划早期诊断可改善 GA-I 患者的生存并减少纹状体损伤。然而,在老龄化患者群体中,临床表型仍在不断发展。最近对 GA-I 患者的长期预后评估发现,肾小球滤过率(GFR)随年龄增长而下降。我们最近创建了首个携带突变 p.R411W(c.1231 C>T)的 GA-I 基因敲入大鼠模型,该突变对应于最常见的 GCDH 人类突变 p.R402W。在这项研究中,我们评估了形式为高赖氨酸饮食(HLD)的急性代谢应激对年轻 Gcdh 大鼠的影响。我们通过重复 Ga-EDTA 正电子发射断层扫描(PET)肾显像、生化和组织学分析,在 Gcdh 大鼠队列的纵向研究中进一步研究了 GCDH 缺乏对肾功能的慢性影响。在暴露于 HLD 的年轻 Gcdh 大鼠中,我们观察到 GFR 下降和肾小管病变的生化迹象。组织学分析显示亲脂性空泡、顶膜刷状缘变薄和近端肾小管(PT)细胞中线粒体数量增加。HLD 还改变了 Gcdh 大鼠肾脏的 OXPHOS 活性和蛋白质组。在纵向队列中,我们显示 Gcdh 大鼠的 GFR 从成年早期开始逐渐下降,肾清除率下降。在老年 Gcdh 大鼠的组织病理学分析中,发现肾小管扩张、PT 细胞中蛋白质积累和单核细胞浸润。这些观察结果证实 GA-I 导致急性和慢性肾损伤。这引发了关于 GA-I 患者肾功能随访的指征和可能的治疗干预以避免肾损伤的问题。